OBJECTIVE: To examine the relationship between GGN and CAG trinucleotide repeat polymorphisms in the androgen receptor (AR) gene and indices of obesity in older Caucasian adults. DESIGN: A cross-sectional study. SUBJECTS: Ninety-nine healthy men (age 51 -93 y) and 113 healthy postmenopausal women (age 51 -92 y). MEASUREMENTS: Genotyping the GGN and CAG repeats of the AR gene, and measuring body weight, height and waist and hip circumferences. Waist was measured at the umbilicus (wstumb), iliac crest (wstili), and mid-way between the iliac crest and lowest rib (wstwst). Waist-to-hip ratios (WHRUMB, WHRILI and WHRWST) and body mass index (BMI) were calculated. RESULTS: Women who were homozygous for a common GGN (17 or 18) and short CAG ( 25) had higher waist and hip circumferences and higher WHRUMB and WHRWST, compared with women without this allele combination. The odds ratios (OR) for the upper 25th percentile of obesity measures were 3.6 -5.6-fold higher for wstumb, wstwst, WHRUMB and WHRWST among women with this allele combination. Men who had both a rare GGN (not 17) and short CAG ( 23) had a higher WHRUMB and WHRILI compared with men without this allele combination. The OR related to the upper 10th percentile of obesity measures among men who had this allele combination was 4.7-fold higher for WHRILI. CONCLUSION: AR GGN and CAG allele combinations are strongly associated with central obesity indices in older adults, particularly in women.
Introduction
Overweight and obesity occur in epidemic proportions in the USA and around the world. Over 50% of adults in the USA and Europe are overweight, and nearly 25% are obese. 1, 2 Obesity increases the risk of age-related diseases, such as cardiovascular and cerebrovascular disease, diabetes and certain cancers. 3 Specifically, obesity that is centrally distributed around the waist is an independent predictor of chronic disease risk. 3 Identifying genes that are related to overall obesity or body fat distribution is imperative for enhanced understanding of the etiology and progression of obesity and age-related disease.
Genetic differences underlying obesity phenotypes are demonstrated by sex-specific differences in the physical patterning of obesity. Men tend to distribute fat around their abdomen (android obesity or apple-shaped), and women tend to distribute fat around their hips (gynoid obesity or pear-shaped). It is well-established that blood sex hormone levels are correlated with body shape. 4 -12 In men, abdominal obesity is generally associated with a lower ratio of androgens to estrogens and lower circulating androgens, 8, 9 whereas in women, abdominal obesity is associated with higher ratios of androgens to estrogens and higher circulating androgens. 9 -12 Thus, genetic variants leading to differences in sex hormone metabolism may be involved in sex-specific obesity patterning.
The androgen receptor plays an important role in regulating androgen action in men and women. The gene coding for the androgen receptor (AR) is located on the X-chromosome at Xq11.2 -q12, and is over 90 kb long. AR codes for a protein that has three major functional domains: an N-terminal domain, a DNA-binding domain, and an androgen-binding domain. AR functions as a steroid hormone-activated transcription factor. Exon 1 in the N-terminal domain of the AR gene contains two polymorphic trinucleotide repeats, GGN and CAG. These polymorphic repeats have been related to alterations in blood sex hormone levels, 13 particularly testosterone, and have been related to sex hormone-dependent cancers, such as prostate and breast cancers. 14 -16 Because of the relationship between AR gene polymorphisms and sex hormone metabolism and sex hormone-related disease, we investigated the relationship between AR GGN and CAG polymorphisms and indices of obesity in older Caucasian women and men.
Subjects and methods

Subjects
A cross-sectional study was conducted that included 218 healthy participants (115 females and 103 males). Participants were selected from a volunteer pool in Cache County, Utah, and greater Utah and Arizona regions. Participants were recruited via advertisements in the newspaper and on community bulletin boards, at local chapters of the American Association for Retired Persons (AARP), at the summer education program for seniors at Utah State University, and via letters to Utah State University alumni.
Interested volunteers were asked to complete an initial telephone questionnaire that screened for a variety of eligibility criteria. Participants were NOT eligible to participate if they: (1) were under 51 y of age; (2) had been diagnosed with abnormalities in hormone metabolism; (3) had a history of invasive cancer; (4) had a history of cardiovascular disease; (5) had a history of menstrual irregularities; (6) ingested exogenous hormones; (7) took cholesterol-lowering medications; (8) smoked cigarettes or other forms of tobacco; (9) consumed more than five alcoholic drinks per week; (10) had recently changed their diet; (11) had recently undergone extreme weight gain or loss (> 20% body weight); or (12) had a body mass index (BMI) of at least 40 kg=m 2 . Eligible participants were asked to make a single visit to the Nutrition and Food Sciences building at Utah State University or to a Quest Diagnostics Clinic in the Salt Lake City area or St George, Utah area to complete the study. Participants were required to provide written consent for sample and data collection according to guidelines outlined by the Utah State University Institutional Review Board. Compensation (blood lipid screen, personal dietary analysis and nutrition brochures) was provided as an incentive for adequate execution and completion of the study, and to emphasize the value of scientific research.
During the visit, participants were required to provide a blood sample, had body measurements taken, and completed diet and lifestyle questionnaires. Participants arrived in the morning having fasted for 12 h with nothing to eat or drink except water and=or medications that did not interfere with the study protocol. Also, participants were asked to refrain from exercising on the morning of the blood draw.
Obesity-related phenotypes Body measurements included weight, height, waist circumferences and hip circumference. Participants were asked to undress to their undergarments and put on a hospital gown. Weight and height measurements were accomplished according to standard techniques. 17 Weight was measured to the nearest 0.25 pound, and height was measured to the nearest 0.25 inch. Measurements were duplicated to ensure accuracy. Waist measurements included circumferences at the (1) umbilicus (wstumb), 18 (2) iliac crest (wstili), 19 and (3) midpoint between the lowest rib and the iliac crest (wstwst). 20 Hip measurements were taken at the greatest diameter of the gluteal muscles. 20, 21 Waist and hip measurements were taken to the nearest 0.50 cm. If a difference greater than 0.50 cm was observed after duplicate measurements, a third measurement was taken until agreement between measurements was within 0.50 cm.
Three waist-hip ratios (WHR) were calculated using the three waist circumference measurements. Wstumb was used to calculate WHRUMB, wstwst was used to calculate WHRWST, and wstili was used to calculate WHRILI. Weight in pounds was converted to kilograms and height in inches was converted to meters. BMI was calculated as the ratio of kilograms per meter squared (kg=m 2 ).
Genotype analyses
Blood samples for genotyping were drawn by a trained phlebotomist into vacutainer tubes containing an acid citrate dextrose solution (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ, USA). DNA was extracted from whole blood within two days of the blood draw. DNA extraction followed a standard protocol. 22 DNA was precipitated using absolute ethanol and solubilized in Tris -EDTA buffer (pH 8.0).
Unique primers were synthesized for amplification of the GGN and CAG repeat regions. DNA sequencing confirmed the regions of interest. The genotyping protocol for the GGN repeat region at the Genomics Core Facility at the University of Utah was according to the following protocol. Polymerase chain reaction (PCR) was performed in a 20 ml reaction consisting of 200 mM dATP and dTTP, 400 mM dCTP and 7-deaza-GTP, 10 mM Tris -HCL, 40 mM NaCl, 2.0 mM MgCl 2 , 0.2 mM Spermidine HCl, 1 U Taq platinum, 0.5 mM each primer, and 10% DMSO. Reactions were cycled in an MJ Research PTC-250 with 5 min initial denaturing at 96 C, then 40 cycles of 60 s at 96 C, 60 s at 58 C, 90 s at 72 C. Two genotyping protocols were used for the CAG repeat region. Sixty-six (eight men, 58 women) samples were analysed by the Genomics Core Facility at the University of Utah according to the following protocol. PCR was performed in a C. One-hundred and forty-six (91 men, 55 women) samples were analysed for the CAG repeat region at Utah State University according to the following protocol. PCR was performed in a 50 ml reaction consisting of 500 mM dNTP, 60 mM Tris -HCl, 3.5 mM MgCl 2 , 2.0 U Taq platinum (Life Technologies), 15 mM ammonium sulfate, and 0.8 mM each primer. Reactions were cycled in an MJ Research PTC-100 with 4 min denaturation at 96 C, then 35 cycles of 1 min at 96 C, 45 s at 57 C, 60 s at 72 C, and a 4 min final extension at 72 C. For both GGN and CAG, all reactions were loaded on denaturing polyacrylamide gels using an internal size standard. All data were analysed using GeneScan and Genotyper software (PE Biosystems, Foster City, CA, USA).
Statistical analyses
Statistical analyses were conducted separately for women and men because of the sex-specific roles of sex hormones related to body shape. Statistical adjustment for age was performed and shown not to be necessary. Means and standard deviations were calculated separately for women and men for all quantitative variables. GGN was analyzed as a categorical variable because of its unique modal distribution. In women, the most frequently occurring GGN allele (mode) was 17, however the two most common GGN alleles were combined and grouped as homozygous for 17 or 18 vs not homozygous for 17 or 18. Thus, using ANOVA, we analyzed mean differences in BMI, hip, wstumb, wstili, wstwst, WHRUMB, WHRILI and WHRWST by GGN allele category equal to 17 or 18 vs not equal to 17 or 18. In men, the GGN mode was 17. Thus, mean differences in anthropometric measures were analysed by GGN allele category equal to 17 vs not equal to 17. CAG was normally distributed and thus analyzed as both a continuous and categorical variable. Pearson correlation coefficients were calculated to assess the linear relationship between CAG and anthropometric variables. In women, the CAG mode for the total population of alleles was 25, thus we analyzed mean differences in BMI, hip, wstumb, wstili, wstwst, WHRUMB, WHRILI and WHRWST by homozygosity for 25 vs > 25 CAG. In men, the CAG mode was 23, thus we analyzed mean differences in anthropometric measures by 23 vs > 23 CAG. Combined GGN and CAG genotypes in women and men were created based on these categories, and based on the direction of the individual relationships between GGN and CAG repeat categories and obesity indices. Chi-square analysis and calculation of the Mantel -Haenzel odds ratios (OR) were used to assess the significance of single and combined high-risk genotypes. In addition to modes, a variety of other cut-off points were used to categorize the GGN and CAG repeats in relationship to anthropometric measures, however these genotype categories were not informative in relationship to anthropometric measurements.
Since CAG repeat number was quantified in two separate laboratories, we compared repeat distributions, and used a multivariate General Linear Model to test whether there was an interaction between laboratory and CAG repeat number in predicting anthropometric measurements. There was no interaction (P ¼ 0.790), thus we combined CAG genotypes from all subjects for statistical analyses. SPSS, version 10.0, was used for statistical analyses.
Results
Complete data were available on 113 (of 115) women (mean age 70.5 y) and 99 (of 103) men (mean age 69.1 y) in this sample. Characteristics of the study population are shown in Table 1 . The range of GGN repeats in women and men was 7 -21, with the most frequently occurring allele being 17 (55% of all GGN alleles in women, 49% in men), followed by 18 (35% of all GGN alleles in women, 38% in men). The range of normally distributed CAG repeats was 13 -32 in women and 12 -31 in men. ). Mean waist circumferences differed (P < 0.001) based on location of waist circumference measurement in women, as did mean WHRs (P < 0.001). Interestingly, the smallest waist measures were noted at wstwst (85.70AE 11.38 cm) and WHRWST (0.847AE 0.068), followed by wstumb AR gene polymorphisms, notably the modes of the repeat distributions, were significantly related to indices of obesity, particularly in women. No linear relationships were observed. In women, homozygosity for a common GGN (17 or 18) was associated with higher mean umbilical (wstumb and WHRUMB), iliac crest (wstili), and waist (wstwst and WHRWST) measurements, and a higher mean hip circumference (Table 2) . Women who were homozygous for a short CAG ( 25) had higher mean umbilical measurements, ie wstumb and WHRUMB (Table 3) . When combined, women who were both homozygous for GGN equal to 17 or 18 and CAG 25, had higher measures of waist at all locations (wstumb, wstili, wstwst), higher WHR at the umbilicus (WHRUMB) and waist (WHRWST), and higher hip circumference vs women who did not have this allele combination ( Table 4 ). The combined GGN and CAG genotype was also related to greater height (161.78 AE 5.72 vs 158.61 AE 8.81 cm, P ¼ 0.024) in women. While the mean differences in anthropometric measurements were similar for the combined genotype vs GGN alone, the P-values tended to be more significant for the combined genotype. In addition, OR associated with the combined genotype for predicting the upper 25% of obesity indices in women were stronger for wstumb, wstwst, WHRUMB, and WHRWST compared to GGN alone (Table 5) . GGN was uniquely related to predicting the upper 25% of hip circumferences.
In men, AR gene polymorphisms were less related to obesity indices. A GGN not equal to 17 Androgen receptor gene repeats and obesity DR Gustafson et al
Discussion
Our data show a strong relationship between two common polymorphisms in the AR gene and indices of central obesity, particularly in women. To our knowledge, the relationship between GGN and CAG repeats in the AR gene and body shape and size in women or men has not been characterized. Over a 5-fold increase in risk of obesity at two physical locations (the umbilicus and at the midpoint between the lowest rib and iliac crest) was observed among the top 25% most obese women who were homozygous for both a common GGN and short CAG genotype. In men, an almost 5-fold increase in risk was associated with having an uncommon GGN and short CAG among the top 10% most obese men based on iliac crest circumference. Numerous physical locations have been used to guide measurement of waist circumference in research studies. 18 -20,23 Subsequently, prediction of health risks differ based on location of the waist circumference measurement. In our study, a high-risk waist circumference of at least 88 cm, was evidenced by 41, 51 and 76% of women based on wstwst, wstumb and wstili, respectively. Using a WHR cut-off point of at least 0.85, 43, 70 and 95% of women were classified as high-risk based on WHRWST, WHRUMB, and WHRILI, respectively. In men, 42% had a mean waist circumference of at least 102 cm, and 91% of the men had a mean WHR of at least 0.90. Studies such as ours provide a rationale for standardization of the waist measurement, since risk classification is greatly affected by the physical location of the measurement, particularly in women.
Variations in the AR gene among women in our sample were also related to high-risk phenotypes according to current criteria for optimal health. Among women, the combined CAG=GGN genotype was related to mean waist circumferences greater than 88 cm and WHRs that were greater than 0.85. In addition, the relationship between these AR polymorphisms and anthropometric measures at different anatomic locations in women and men indicates a potentially differential role of androgen metabolism on body shape and size based on sex.
The role of the AR gene in relationship to body shape may very well be due to the effect of AR gene variations on sex hormone levels. In premenopausal women, homozygosity for a shorter CAG repeat ( 19) was related to higher blood testosterone levels. 13 This finding fits well with our data showing that a shorter CAG repeat is related to central distribution of body fat in postmenopausal women, since some data show that central obesity may be associated with higher circulating levels of androgens in women. 24 However in men, an inverse relationship between repeat length and transcriptional activity of AR has previously been shown. 25 Thus, a shorter repeat length (suggesting a more active receptor) has been related to lower blood testosterone levels and greater age-related testosterone decline; 26 and low blood testosterone levels are related to, 27 and perhaps predictive of, 8 higher WHR in men. It appears that the length of the CAG repeat may influence androgen metabolism differently in men vs women, and in our study, be more influential of body shape in women.
While our data are very interesting, and point to a unique genotype -phenotype relationship, there are potential limitations of this study. First, these data are representative for an older population of men and postmenopausal women. We chose to study older adults because of the relative stability of body shape phenotypes at older ages compared to other stages of life, such as puberty and early and middle adulthood. For example, the gain in body fat during puberty in women is most likely to be in the hips and thighs, whereas the gain in body fat during adult years that accompanies pregnancy and menopause, is more likely to be centrally distributed, 28 and thus more predictive for diseases of late life. Second, these data are representative for a relatively healthy population. Criteria for inclusion (eg non-smokers) and exclusion (eg a history of cardiovascular disease or cancer, use of cholesterol-lowering medications) in the study were used because we wanted to assess healthy individuals who were not in a state of 'phenotypic flux'. Individuals who are in the process of lifestyle modification (eg losing weight or increasing exercise levels) are experiencing a variety of physiological alterations, which may have led to spurious results. Third, it was necessary to recruit only a European Caucasian sample due to the ethnic variation that has been observed in the distribution of AR CAG 29 Fourth, the number of participants in this study is relatively small, therefore these analyses should be repeated in a larger population. Fifth, the range of anthropometric measurements in this study is limited due to the general health exclusion criteria that were used and the final sample size. It would be interesting, for example, to note the relationship between AR gene polymorphisms and body shape and size in individuals who are extremely obese. Sixth, other genes have shown potential relationships to obese phenotypes. Perhaps a combination of genes, in addition to altered biochemical parameters, will allow identification of those who are predisposed to obesity.
This study points to the unique role of AR gene CAG and GGN polymorphisms in the manifestation of body shape, particularly in older women. Further investigation should be accomplished to elucidate the multifactorial etiology of obesity in relationship to AR and other gene polymorphisms. Consideration should be given to genes related to specific measures of central obesity. Since waist circumference is independently related to chronic disease risk, identifying the best location for the waist circumference measurement will help refine relationships between obesity and disease.
